← Back to Clinical Trials
Recruiting NCT06249906

Efficacy of Bioceramic Materials for Bone Defects Repair

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Bone Lesion
Sponsor Nanjing First Hospital, Nanjing Medical University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-02-20
Completion 2026-09-30
Interventions
Commercial bone implant product GroupMirco-structured Bioceramic Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to demonstrate the effect of bioceramic implants on the repair of human bone defects, and to explore the application of bioceramic materials in bone defects, bone implantation, and bone fusion. The surface microstructure of β-tricalcium phosphate bioceramic implants can be effectively controlled to guide the regeneration of bones, promote the restoration of bones, accelerate the speed of recovery, and improve bone quality, which is of great clinical and social significance.

Eligibility Criteria

Inclusion Criteria: 1. Patients who voluntarily take the test and sign the informed consent form; 2. Patients aged 18-65 years old with no history of allergies; 3. Patients able to communicate well with the investigator and follow the requirements of the entire trial. Exclusion Criteria: 1. Patients who refuse to sign the informed consent form to participate in the trial; 2. Patients who are not in the age range of 18 to 65 years; 3. Patients with diseases unsuitbale for the trial: history of allergies, severe cardiopulmonary disease, coagulation dysfunction, Alzheimer's disease, cerebral atrophy, acute phase or sequelae of cerebrovascular disease, cognitive impairment; 4. Patients in the acute phase of local or systemic bacterial infections; 5. Patients who cannot cooperate with the operation and evaluate the effect; 6. Other conditions that are considered inappropriate by the investigator to participate in the study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}